Abstract
Ovarian cancer (OC) is the deadliest gynecologic malignancy largely due to asymptomatic early progression of OC cells, late-stage diagnosis of the tumor, and the resistance of tumor cells to standard treatments. The most prevalent OC subtype, high-grade serous ovarian carcinoma (HGSOC), is the primary cause of most OC-related deaths.
Status
Graduate
Department
Biomedical Engineering
College
Russ College of Engineering and Technology
Campus
Athens
Faculty Mentor
Fabian Benencia
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Effects of BX795, GSK8612, and MRT67307 on Mouse and Human Ovarian Cancer Cell Lines
Ovarian cancer (OC) is the deadliest gynecologic malignancy largely due to asymptomatic early progression of OC cells, late-stage diagnosis of the tumor, and the resistance of tumor cells to standard treatments. The most prevalent OC subtype, high-grade serous ovarian carcinoma (HGSOC), is the primary cause of most OC-related deaths.